Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Australian Clinical Labs Completes $22 Million Share Buy-Back, Below Its 19.5 Million-Share Cap

ACL: $3.32 +2.15% · MC: $619M

Australian Clinical Labs’ final notification records that it bought back about 9.3 million shares for approximately $22 million, below the authorised maximum of 19.5 million shares. The on-market buy-back ran from November 2025 to November 2026 and was subject to the company’s capital position and other factors.

Source announcements: 2026-11-11 08:47 to 2026-11-11 08:47 Sydney time
Story updated 2026-11-11 08:53 Sydney time
SourcesUpdate - Notification of buy-back - ACL
Comments